Locations:
Search
Search is on for genetic markers in 500-patient sample
Profile of six ongoing studies aiming to overcome anatomic hurdles
Results presented at VIVA 17 pave way for DETOUR II pivotal trial
Large analysis offers most definitive insights yet into ‘diabetes paradox’
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Celecoxib has least impact, followed by naproxen and ibuprofen
ACCELERATE substudy shows no benefit of evacetrapib in patients with diabetes
Post hoc analysis suggests more heart failure patients might benefit
Progress in quest for autoimmune mechanisms behind idiopathic dilated CM
Findings call for revisiting readmission prevention strategies
Matched cohort study finds marked survival disadvantage with radiation
Advertisement
Advertisement